Views & Analysis Getting a rarer perspective Benefitting from insights from focus groups with rare disease patients.
Views & Analysis Patient-centricity and long-term conditions – where next? Comprehensive guidance, education and training are vital to upskill clinicians and others in patient-centred healthcare.
Views & Analysis The continuing rise of patient-centrists (and how we can hel... Communications agencies can assist pharma in putting the patient at the heart of business.
Views & Analysis Patient-centric trials – dream or reality? Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
Views & Analysis IBM Watson: a holistic approach to health Kyu Rhee, chief health officer, speaks about the company's impact and aspirations in health.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
